skip to Main Content
Dr. Sapna Syngal in a portait photo in her office

GENERATE Trial Expands Eligibility

Dr. Sapna Syngal explains the expanded eligibility standards for the GENERATE Study for genetic testing of pancreatic cancer patients and relatives.

Portrait photo of Dr. Ryan Nipp

New Study Focuses On Supportive Oncology Care At Home

For some newly diagnosed patients with borderline resectable tumors or locally advanced disease, neoadjuvant therapy is proving to be a game-changer. One such neoadjuvant approach uses FOLFIRINOX, a combination of the drugs leucovorin, fluorouracil, irinotecan, and oxaliplatin. Preoperative treatment with this regimen shows the potential to improve the odds of an R0 resection, meaning no…

Back To Top